Clinical trial Recruiting at 1 site Observational

Registry study on the life cycle of patients with congenital heart disease

Official title: A Comprehensive Registry Study of the Whole Life Cycle of Patients With Congenital Heart Diseases

Run by Beijing Anzhen Hospital · NCT06611787 · Data updated 2026-11-12

This study looks at how congenital heart disease affects patients in China from pregnancy through their entire lives to see how to improve their care and treatment.

More Congenital Heart Disease trials

Quick facts

Study typeObservational
SexAll
Enrollment100000 (estimated)
SponsorBeijing Anzhen Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedFebruary 2, 2024
Main results expectedJanuary 1, 2029
Study endsJanuary 1, 2030
Registry record updatedSeptember 25, 2024
Trial IDNCT06611787 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients diagnosed with various forms of congenital heart disease.

Probably not a fit

Patients with congenital heart disease who are not receiving treatment or intervention may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects data on the prevalence, interventions, and prognosis of congenital heart disease (CHD) in Chinese patients throughout their lives. It covers the entire spectrum from fetal diagnosis to neonatal treatment and standardized care during pregnancy for CHD patients. The study employs a cyclical model of evaluation, training, improvement, and re-evaluation to enhance the diagnostic and treatment capabilities of participating hospitals, particularly for complex cases. The ultimate goal is to improve medical services and develop treatment guidelines for CHD in China.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic and treatment standards for congenital heart disease in China.

How similar studies have gone: Other studies focusing on registry data for congenital heart disease have shown success in improving treatment outcomes and standardizing care.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with various congenital heart diseases

Exclusion Criteria:

* None

Where it's running

  • Beijing AnZhen Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.